“Go woke, go broke” has become a well-known saying. Does it stack up against the evidence?
It’s little-known, but The Economist has over 1,000 shareholders. It’s akin to an exclusive club, which rather wants to keep you out. Will you be able to buy stock regardless – and could a proper IPO beckon?
Would you like to learn more about investments in Asia, but haven’t found the right resource yet? Asian Century Stocks will help you broaden your horizon.
German blue chip Bayer is currently down and out. 2022 should bring a turnaround, though, similar to the one seen at Volkswagen.
This European entertainment champion is looking to turn itself into a global giant - and could gain 125% by mid-2022.
Can coronavirus vaccine maker Novavax profit from the vast majority of unvaccinated people, and make vaccine sceptics fall in love with it?
